TR200402689A2 - Yeni ornidazol formülasyonu. - Google Patents

Yeni ornidazol formülasyonu.

Info

Publication number
TR200402689A2
TR200402689A2 TR2004/02689A TR200402689A TR200402689A2 TR 200402689 A2 TR200402689 A2 TR 200402689A2 TR 2004/02689 A TR2004/02689 A TR 2004/02689A TR 200402689 A TR200402689 A TR 200402689A TR 200402689 A2 TR200402689 A2 TR 200402689A2
Authority
TR
Turkey
Prior art keywords
ornidazole
formulation
new
trichomonasis
amebiasis
Prior art date
Application number
TR2004/02689A
Other languages
English (en)
Inventor
Eği̇lmez Vedat
Original Assignee
Abdi̇ İbrahi̇m İlaç Sanayi̇ Ve Ti̇caret A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abdi̇ İbrahi̇m İlaç Sanayi̇ Ve Ti̇caret A.Ş. filed Critical Abdi̇ İbrahi̇m İlaç Sanayi̇ Ve Ti̇caret A.Ş.
Priority to TR2004/02689A priority Critical patent/TR200402689A2/tr
Publication of TR200402689A2 publication Critical patent/TR200402689A2/tr

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu buluş, Amebiasis, Trikomonasis ve Giardiasis tedavisinde kullanılacak birim dozaj formunda 1500 mg Ornidazol içeren oral tablet ile ilgilidir.
TR2004/02689A 2004-10-14 2004-10-14 Yeni ornidazol formülasyonu. TR200402689A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2004/02689A TR200402689A2 (tr) 2004-10-14 2004-10-14 Yeni ornidazol formülasyonu.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2004/02689A TR200402689A2 (tr) 2004-10-14 2004-10-14 Yeni ornidazol formülasyonu.

Publications (1)

Publication Number Publication Date
TR200402689A2 true TR200402689A2 (tr) 2006-05-22

Family

ID=36638081

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/02689A TR200402689A2 (tr) 2004-10-14 2004-10-14 Yeni ornidazol formülasyonu.

Country Status (1)

Country Link
TR (1) TR200402689A2 (tr)

Similar Documents

Publication Publication Date Title
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
NO20063430L (no) Generelt lineaer, brusende oral fentanyl doseringsform, og metoder for administrering
SE0301700D0 (sv) Novel compounds
TW200605882A (en) Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
MY143407A (en) Indazole derivatives as inhibitors of hormone sensitive lipase
SG166093A1 (en) Inhibitors of brutonæs tyrosine kinase
DK1654253T3 (da) Substituerede 3-pyrrolidinindolderivater
NO20091734L (no) Glucagonreseptorantagonistforbindelser, preparater inneholdende slike forbindelser, og metoder for anvendelse
GEP20094845B (en) Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
MY158162A (en) 5-membered heterocycle-based p38 kinase inhibitors
TW200621763A (en) Lactam compounds and their use as pharmaceuticals
TR199901417T2 (tr) Analjezik etkisi olan yeni bilesimler.
MX2009003372A (es) Formas de dosificacion de pelicula no mucoadhesiva.
CL2008001303A1 (es) Compuestos derivados de heterociclos, moduladores de gamma secretasa; composicion farmaceutica; kit farmaceutico; y uso en el tratamiento del alzheimer.
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
MY144897A (en) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
ATE543491T1 (de) Kombinationspräparat enthaltend ibuprofen und paracetamol
CY1107906T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει παραγωγα οιστετρολης για χρηση στην θεραπεια κατα του καρκινου
FR2878161B1 (fr) Forme medicamenteuse orale, solide et concue pour eviter le mesusage
FR2869540B1 (fr) Compositions pharmaceutiques contenant des derives de b-carboline, et leur utilisation pour le traitement des cancers
WO2006076097A3 (en) Stable non-crystalline formulation comprising losartan
SE0300457D0 (sv) Novel compounds
TW200611697A (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
TR200301553A1 (tr) İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar
RS20050756A (en) Oral pharmaceutical preparation for proton pump antagonists